{"Title": "Further thoughts about the ILLUMINATE studies of tabalumab in SLE", "Year": 2016, "Source": "Ann. Rheum. Dis.", "Volume": "75", "Issue": 2, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 4, "DOI": "10.1136/annrheumdis-2015-208709", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84954309790&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antibodies, Monoclonal", "B-Cell Activating Factor", "Female", "Humans", "Lupus Erythematosus, Systemic", "Male"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84954309790", "SubjectAreas": [["Immunology and Allergy", "MEDI", "2723"], ["Rheumatology", "MEDI", "2745"], ["Immunology", "IMMU", "2403"], ["Biochemistry, Genetics and Molecular Biology (all)", "BIOC", "1300"]], "AuthorData": {"57201108555": {"Name": "Isenberg D.", "AuthorID": "57201108555", "AffiliationID": "60022148", "AffiliationName": "Division of Medicine, UCL, Centre for Rheumatology Research"}}}